Effects of photodynamic therapy mediated by emodin in cervical carcinoma cells.

Photodiagnosis and Photodynamic Therapy
Ana Emília Brumatti Galiardi-CampoyMarilia Freitas Calmon

Abstract

Cervical cancer is a worldwide public health problem, and improved selective therapies and anticancer drugs are urgently needed. In recent years, emodin has attracted considerable attention due to its anti-inflammatory, antineoplastic, and proapoptotic effects. Furthermore, emodin may be used as a photosensitizing agent in photodynamic therapy. Interest in photodynamic therapy for cancer treatment has increased due to its efficiency in causing tumor cell death. This study aimed to analyze the effect of emodin combined with photodynamic therapy in cervical carcinoma cell lines. At first, emodin presented cytotoxicity in concentration and time-dependent manners in all the specific cell lines analyzed. SiHa, CaSki, and HaCaT cancer cells presented more than 80% cell viability in concentrations below 30 µmol/L. Fluorescence microscopy images showed efficient cellular uptake of emodin in all analyzed cell lines. A significant decrease in cell viability was observed in SiHa, CaSki, and HaCaT cell lines after treatment of emodin combined with photodynamic therapy. These decreases were accompanied by increased ROS production, caspase-3 activity, and fluorescence intensity of autophagic vacuoles. This suggests increased ROS production l...Continue Reading

References

Dec 4, 2001·European Journal of Pharmacology·H Z LeeC H Wu
Mar 15, 2003·Nature Reviews. Cancer·John Mann
Jan 20, 2005·Molecular and Cellular Biology·Patricia BoyaGuido Kroemer
Apr 6, 2005·Biochemistry. Biokhimii︠a︡·M BrasS A Susin
Jul 10, 2007·Bioscience, Biotechnology, and Biochemistry·Zeng-hui TengQi-bing Mei
Sep 5, 2007·The International Journal of Biochemistry & Cell Biology·Gaëlle BouletJohannes Bogers
Feb 6, 2008·Lasers in Medical Science·K PlaetzerT Kiesslich
Feb 26, 2008·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Patricia Marçal da CostaCláudia Pessoa
Sep 16, 2010·European Journal of Pharmacology·Hong-Zin LeeDa-Tian Bau
Dec 18, 2010·Expert Review of Clinical Immunology·Pawel MrozMichael R Hamblin
Apr 26, 2011·Methods in Molecular Biology·Johan van MeerlooJacqueline Cloos
Apr 20, 2012·Journal of Photochemistry and Photobiology. B, Biology·Samuel T SaitoMartin Brendel
May 18, 2012·Proceedings of the National Academy of Sciences of the United States of America·Tim Willinger, Richard A Flavell
Jul 19, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Pao-Hsuan HuangHo Lin
Jul 23, 2013·Nature·Natalia L Komarova, C Richard Boland
Jul 22, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Mei-Juan XieYuan-Yuan Lu
Aug 16, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Jia-Qi SuiMing-Jie Xie
Aug 22, 2014·International Journal of Nanomedicine·Giovana CalixtoMarlus Chorilli
Oct 20, 2014·Nature Chemical Biology·Baptiste RonanBenoit Pasquier
Mar 10, 2015·Molecular Cancer·Zhenyi SuQiang Yu
Mar 19, 2015·PloS One·Pooja Chandrakant Thacker, Devarajan Karunagaran
Jul 25, 2015·Endocrine-related Cancer·Laura A MarlowJohn A Copland
Aug 19, 2015·Frontiers in Oncology·Malgorzata WachowskaJakub Golab
Oct 9, 2015·Journal of Receptor and Signal Transduction Research·Harmit S Ranhotra
Nov 14, 2015·Autophagy·Michael J Munson, Ian G Ganley
Nov 30, 2015·Biochemistry. Biokhimii︠a︡·M A Savitskaya, G E Onishchenko
Apr 25, 2016·Apoptosis : an International Journal on Programmed Cell Death·Qiu HuangPing-Hua Tu
May 18, 2016·Phytotherapy Research : PTR·Xiaoxv DongJian Ni
Jul 30, 2016·Acta Pharmaceutica Sinica. B·Eun Ji HongMin Suk Shim
Oct 11, 2016·Chemical Society Reviews·Zijian ZhouXiaoyuan Chen
Jan 10, 2017·Journal of Cellular Physiology·Shuling SongQiang Zhang
May 4, 2017·Cancer·William SmallDavid K Gaffney
May 23, 2017·Mutation Research. Reviews in Mutation Research·Suruchi Mittal, Lawrence Banks
Sep 25, 2017·Apoptosis : an International Journal on Programmed Cell Death·Zhengzhi ZouSongmao Wang
Oct 14, 2017·Marine Drugs·Cinzia CalcabriniCarmela Fimognari
Feb 16, 2018·Neoplasia : an International Journal for Oncology Research·Elizabeth M MatthewWafik S El-Deiry

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms